Salvage therapy for hepatocellular carcinoma with thalidomide

Table 6 Response rate of hepatoma treated with thalidomide

	Tumor response		Stabilization rate
	N	CR/PR	SD	PD	(PR + SD)
Patt et al[6]	21	0/1	11	9	12 (57%)
Chen et al[8]	42	0/2	15	25	17 (43%)
Kong et al[5]	11	0/1	4	6	5 (45%)
Lin et al[4]	27	0/1	1	25	2 (8%)
Schwartz et al[7]	20	1/1	7	11	9 (45%)
Total	121	1/6	38	76	45 (37%)
Wang et al	99	0/6	Survival 16 upto Apr 31 ’03

CR: complete response, PR: partial response, SD: stable disease, PD: Progressive disease.